Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000213719

Medchemexpress LLC 1-[(4-tert-butylphenyl)methyl]-3-[[3-fluoro-4-(methanesulfonamido)phenyl]methyl]thiourea | 401907-26-4 | MFCD29770787 | 99.5% | 423.57 g/mol | C20H26FN3O2S2 | 10 MG
SDP

Catalog No. 5000213719
Encompass_Preferred

Small-molecule TRPV1 receptor antagonist supplied for research use. It inhibits TRPV1 with an IC50 of 8 nM, is supplied as a solid powder with high reported purity, and is suitable for in vitro and in vivo pharmacology studies. Solubility in DMSO and recommended storage conditions are provided to support experimental use.

  • Potent TRPV1 antagonism with IC50 of 8 nM.
  • High reported purity for reliable experimental results.
  • Supplied as a solid powder suitable for long-term storage.
  • Soluble in DMSO; in vivo formulation protocols provided.
  • Storage recommendations for powder and solutions included.

Catalog No. 50-002-13719 Supplier Medchemexpress LLC Supplier No. HY10066810MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Small-molecule TRPV1 receptor antagonist supplied for research use. It inhibits TRPV1 with an IC50 of 8 nM, is supplied as a solid powder with high reported purity, and is suitable for in vitro and in vivo pharmacology studies. Solubility in DMSO and recommended storage conditions are provided to support experimental use.

  • Potent TRPV1 antagonism with IC50 of 8 nM.
  • High reported purity for reliable experimental results.
  • Supplied as a solid powder suitable for long-term storage.
  • Soluble in DMSO; in vivo formulation protocols provided.
  • Storage recommendations for powder and solutions included.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.